MAPT and Alzheimer disease: DM1 is considered a tauopathy, as NFTs have been found in amygdala, hippocampus, entorhinal cortex, and temporal cortex of DM1 brains, with a topographic distribution similar to that reported for moderate AD, yet to a lesser extent, and this may be the first reason why data regarding tau in blood from DM1 patients are less robust [13].